Huberman Lab
Dr. Peter Attia: Supplements for Longevity & Their Efficacy
Dr. Peter Attia
But the point is, like, nobody has a commercial interest in rapamycin. It's sort of an irrelevant drug, but the interest is scientific. The commercial interest is in what we call rapalogs, which are analogs of rapamycin that are being investigated by a number of companies to look at new indications. For example, immunity, immune function.
0
💬
0
Comments
Log in to comment.
There are no comments yet.